TY - JOUR
T1 - Importance of helper T-cell activation in dendritic cell-based anticancer immunotherapy
AU - Schreibelt, Gerty
AU - Bol, Kalijn F.
AU - Aarntzen, Erik H. J. G.
AU - Gerritsen, Winald R.
AU - Punt, Cornelis J. A.
AU - Figdor, Carl G.
AU - de Vries, I. Jolanda M.
PY - 2013
Y1 - 2013
N2 - Dendritic cell-based anticancer immunotherapy is feasible, safe and results in the induction of tumor-specific immune responses, at least in a fraction of vaccinated patients. The concomitant activation of cytotoxic and helper T cells, by loading DCs with peptides or electroporating them with the corresponding mRNAs, may further enhance vaccine-induced antitumor responses
AB - Dendritic cell-based anticancer immunotherapy is feasible, safe and results in the induction of tumor-specific immune responses, at least in a fraction of vaccinated patients. The concomitant activation of cytotoxic and helper T cells, by loading DCs with peptides or electroporating them with the corresponding mRNAs, may further enhance vaccine-induced antitumor responses
U2 - https://doi.org/10.4161/onci.24440
DO - https://doi.org/10.4161/onci.24440
M3 - Editorial
C2 - 23894702
SN - 2162-4011
VL - 2
SP - e24440
JO - Oncoimmunology
JF - Oncoimmunology
IS - 6
ER -